Avian Flu Treatment Market

Future Market Insights

Key Insight

The avian flu treatment market is projected to grow from USD 1.3 billion in 2025 to USD 3.0 billion by 2035, at a CAGR of 8.8%. Antivirals will dominate with a 30.2% market share, while hospital will lead the end user segment with a 52.4% share.

September 30, 2025

Anurag Sharma

250 Pages

Cite this Report

Avian Flu Treatment Market

https://www.futuremarketinsights.com/reports/avian-flu-treatment-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Abbott
BioCryst Pharmaceuticals
Cipla Ltd
Forrest Pharmaceuticals
GlaxoSmithKline [GlaxoSmithKline]
Macleods Pharmaceuticals Ltd
Pfizer [Pfizer]
Roche [Roche]
Sanofi [Sanofi]
Sinovac Biotech Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Avian Flu Treatment Market

Key Players

Similar Industry Reports